Epitopes Required for Antibody‐Dependent Enhancement of Ebola Virus Infection
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s2) , S347-S356
- https://doi.org/10.1086/520581
Abstract
We have shown that antibody-dependent enhancement (ADE) of infection with Zaire Ebola virus (ZEBOV) is mediated by interaction of virus-specific antiKeywords
This publication has 25 references indexed in Scilit:
- Protective efficacy of neutralizing antibodies against Ebola virus infectionVaccine, 2006
- Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesNature Medicine, 2005
- Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeysThe Lancet, 2003
- Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implicationsReviews in Medical Virology, 2003
- Antibody-Dependent Enhancement of Ebola Virus InfectionJournal of Virology, 2003
- Identification of Protective Epitopes on Ebola Virus Glycoprotein at the Single Amino Acid Level by Using Recombinant Vesicular Stomatitis VirusesJournal of Virology, 2003
- Infectivity-Enhancing Antibodies to Ebola Virus GlycoproteinJournal of Virology, 2001
- C1q—how many functions? How many receptors?Trends in Cell Biology, 1998
- The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.Proceedings of the National Academy of Sciences, 1996
- GP mRNA of Ebola Virus Is Edited by the Ebola Virus Polymerase and by T7 and Vaccinia Virus Polymerases1Virology, 1995